A new survey carried out by MS Society in Britain has found that just two in five patients who are eligible for multiple sclerosis drugs are taking them.
Over 10,000 multiple sclerosis patients took part in the survey with the researchers finding that majority of the patients were missing on seven licensed medicines approved for treating MS.
AdvertisementThe researchers added that one of the major reasons for patients not taking the drugs was the lack of information and access to specialists and added that the government should come out with a personalized care plan to every person with MS.
"This could be due to barriers to accessing medicines; because individuals make an informed decision not to take them; or because they don't know what information is out there that they could have access to, such as around new treatments or new evidence of efficacy", the researchers wrote in their report.
You May Also Like